First published · Last updated
Construction of efficacy prediction model for T-DXd treatment of HER2-positive and HER2-low expression breast cancer based on hematological indicators: A real-world study
A real-world journal article reports construction of an efficacy prediction model for T-DXd treatment of HER2-positive and HER2-low expression breast cancer using hematological indicators. Publisher is listed as Elsevier BV and publication date is 2027-02-01.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 2/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
The study presents a predictive model for efficacy of T-DXd treatment in HER2-positive and HER2-low breast cancer.

